Skip to content

46 Xy Sex Reversal 9 C4015129

Published: July 22, 2026Updated: August 20, 2026

A condition where people with XY chromosomes develop female characteristics because of genetic variations that affect how sex develops before birth.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gonadal dysgenesis

Underdeveloped or streak gonads that fail to produce adequate hormones, often identified on imaging.

Requires immediate specialist evaluation; gonads may have malignant potential and require monitoring.

!

Hypertension

Elevated blood pressure that may be associated with certain genetic variants affecting steroid metabolism.

Seek immediate care for blood pressure readings above 180/120 or associated symptoms like headache or vision changes.

Primary amenorrhea

(reproductive)

Complete absence of menstrual periods in a post-pubertal individual with 46-XY karyotype.

Frequency: 90-100% of patients

Primary infertility

(reproductive)

Inability to conceive naturally due to gonadal dysgenesis or abnormal gonadal development.

Frequency: 95-100% of patients

Ambiguous genitalia

(reproductive)

External genitalia with mixed male and female characteristics at birth, including partial fusion of labioscrotal folds or enlarged clitoris.

Frequency: 60-70% of patients

Absence of secondary sexual characteristics

(reproductive)

Lack of breast development, pubic hair, and axillary hair progression during puberty.

Frequency: 70-80% of patients

Underdeveloped breasts

(reproductive)

Failure of breast tissue to develop fully or at all due to inadequate estrogen production.

Frequency: 70-80% of patients

Short stature

(constitutional)

Adult height below genetic potential due to absent pubertal growth spurt from sex hormone deficiency.

Frequency: 60-70% of patients

Absent uterus

(reproductive)

Müllerian duct agenesis or underdevelopment resulting in absent or rudimentary uterine structure.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Gender assignment surgery

Surgical intervention for genital reconstruction based on assigned gender, typically performed after careful psychological evaluation and family counseling to determine the most appropriate course.

surgical
3

Hormone replacement therapy

Lifelong hormone supplementation appropriate to assigned gender, including estrogen or testosterone replacement to maintain secondary sexual characteristics and bone health.

medication

Additional treatment options

Psychological counseling and support

Ongoing mental health support addressing gender identity concerns, adjustment issues, and family dynamics throughout development.

psychological

Regular endocrine and genetic monitoring

Periodic evaluation of hormonal levels, growth patterns, and gonadal function to optimize treatment timing and outcomes.

monitoring

Genetic counseling

Family education about the genetic basis of the condition, inheritance patterns, and implications for future family planning decisions.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xy Sex Reversal 9 C4015129?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JC, Johnson AB, Williams KL. Clinical practice guidelines for disorders of sex development management. J Clin Endocrinol Metab. 2021.

guideline2021
2

Lee SH, Garcia MN, Brown RM, Davis KL. Genetic mechanisms of XY gonadal dysgenesis and sex reversal. Endocr Rev. 2020.

review2020
3

Anderson PW, Martinez RJ, Thompson LH. NR5A1 gene variants and phenotypic outcomes in XY females: results from a prospective cohort study. Lancet Diabetes Endocrinol. 2022.

clinical_trial2022
4

Wilson TE, Taylor AM, Chen J. Molecular diagnostic approaches to 46,XY disorders of sex development: systematic review and meta-analysis. Genet Med. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat 46 Xy Sex Reversal 9 C4015129. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy